Photo from wikipedia
Coronavirus disease‐19 (COVID‐19) “lockdowns” caused an abruptly restricted access to health care services such as immunotherapy for allergic rhinitis (AR) and led to higher exposure to indoor allergens. This study… Click to show full abstract
Coronavirus disease‐19 (COVID‐19) “lockdowns” caused an abruptly restricted access to health care services such as immunotherapy for allergic rhinitis (AR) and led to higher exposure to indoor allergens. This study aimed to assess the impact of COVID‐19 lockdowns on AR symptoms reported by the patients treated with immunotherapy who attended the Hospital Fundación Santa Fe de Bogotá and Unidad Médico Quirúrgica de Otorrinolaringología, Colombia.
Keywords:
patients treated;
impact covid;
treated immunotherapy;
allergic rhinitis
Journal Title: Laryngoscope Investigative Otolaryngology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Laryngoscope Investigative Otolaryngology
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!